These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4200059)

  • 1. Research on dengue in tissue culture. V. Production of anti-dengue antibodies in tissue cultures from monkeys inoculated with an attenuated type I dengue virus strain.
    Fujita N; Izaki S; Oda K; Kimura E; Hotta S
    Kobe J Med Sci; 1972 Sep; 18(3):143-52. PubMed ID: 4200059
    [No Abstract]   [Full Text] [Related]  

  • 2. Research on dengue in tissue culture. 3. Immunogenic effect of a tissue-cultured (human-attenuated) type I virus strain.
    Hotta S; Fujita N; Shimazu Y; Yasui Y; Okubo Y
    Kobe J Med Sci; 1966 Dec; 12(4):199-205. PubMed ID: 4964378
    [No Abstract]   [Full Text] [Related]  

  • 3. Dengue virus vaccine studies in Puerto Rico: a review.
    Kraiselburd E
    P R Health Sci J; 1987 Apr; 6(1):27-9. PubMed ID: 3615798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chimeric dengue type 2/type 1 viruses induce immune responses in cynomolgus monkeys.
    Butrapet S; Rabablert J; Angsubhakorn S; Wiriyarat W; Huang C; Kinney R; Punyim S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):589-99. PubMed ID: 12693596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and immunity of dengue infection in man.
    Hotta S
    Kobe J Med Sci; 1972 Dec; 18(4):199-210. PubMed ID: 4200060
    [No Abstract]   [Full Text] [Related]  

  • 6. Dengue-3 (16562) PGMK 33 vaccine: neurovirulence, viremia and immune responses in Macaca fascicularis.
    Angsubhakorn S; Yoksan S; Pradermwong A; Nitatpattana N; Sahaphong S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1994 Sep; 25(3):554-9. PubMed ID: 7777925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.
    Sun W; Nisalak A; Gettayacamin M; Eckels KH; Putnak JR; Vaughn DW; Innis BL; Thomas SJ; Endy TP
    J Infect Dis; 2006 Jun; 193(12):1658-65. PubMed ID: 16703509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurovirulence effects of dengue-2 viruses on the rhesus (Macaca mulatta) brain and spinal cord.
    Angsubhakorn S; Moe JB; Marchette NJ; Palumbo NE; Yoksan S; Bhamarapravati N
    Southeast Asian J Trop Med Public Health; 1987 Mar; 18(1):52-5. PubMed ID: 3660068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.
    Robert Putnak J; Coller BA; Voss G; Vaughn DW; Clements D; Peters I; Bignami G; Houng HS; Chen RC; Barvir DA; Seriwatana J; Cayphas S; Garçon N; Gheysen D; Kanesa-Thasan N; McDonell M; Humphreys T; Eckels KH; Prieels JP; Innis BL
    Vaccine; 2005 Aug; 23(35):4442-52. PubMed ID: 16005749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
    Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
    Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on dengue in tissue culture. IV. Serologic responses of human beings to combined inoculations of attenuated, tissue-cultured type I dengue virus and yellow fever vaccine.
    Fujita N; Oda K; Yasui Y; Hotta S
    Kobe J Med Sci; 1969 Dec; 15(4):163-80. PubMed ID: 4317037
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris.
    Guzmán MG; Rodríguez R; Rodríguez R; Hermida L; Alvarez M; Lazo L; Muné M; Rosario D; Valdés K; Vázquez S; Martinez R; Serrano T; Paez J; Espinosa R; Pumariega T; Guillén G
    Am J Trop Med Hyg; 2003 Aug; 69(2):129-34. PubMed ID: 13677367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation by flow cytometry of antibody-dependent enhancement (ADE) of dengue infection by sera from Thai children immunized with a live-attenuated tetravalent dengue vaccine.
    Guy B; Chanthavanich P; Gimenez S; Sirivichayakul C; Sabchareon A; Begue S; Yoksan S; Luxemburger C; Lang J
    Vaccine; 2004 Sep; 22(27-28):3563-74. PubMed ID: 15315835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults.
    Kitchener S; Nissen M; Nasveld P; Forrat R; Yoksan S; Lang J; Saluzzo JF
    Vaccine; 2006 Feb; 24(9):1238-41. PubMed ID: 16213632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the immunization of monkeys against dengue. I. Protection derived from single and sequential virus infections.
    Halstead SB; Casals J; Shotwell H; Palumbo N
    Am J Trop Med Hyg; 1973 May; 22(3):365-74. PubMed ID: 4196288
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and immunogenicity of a three dose regimen of two tetravalent live-attenuated dengue vaccines in five- to twelve-year-old Thai children.
    Sabchareon A; Lang J; Chanthavanich P; Yoksan S; Forrat R; Attanath P; Sirivichayakul C; Pengsaa K; Pojjaroen-Anant C; Chambonneau L; Saluzzo JF; Bhamarapravati N
    Pediatr Infect Dis J; 2004 Feb; 23(2):99-109. PubMed ID: 14872173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the immunization of monkeys against dengue. II. Protection following inoculation of combinations of viruses.
    Halstead SB; Palumbo NE
    Am J Trop Med Hyg; 1973 May; 22(3):375-81. PubMed ID: 4196289
    [No Abstract]   [Full Text] [Related]  

  • 19. Induction of neutralizing antibodies against dengue virus type 2 upon mucosal administration of a recombinant Lactococcus lactis strain expressing envelope domain III antigen.
    Sim AC; Lin W; Tan GK; Sim MS; Chow VT; Alonso S
    Vaccine; 2008 Feb; 26(9):1145-54. PubMed ID: 18243432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroepidemiological survey on dengue and Japanese encephalitis virus infections in Asian monkeys.
    Yuwono J; Suharyono W; Koiman I; Tsuchiya Y; Tagaya I
    Southeast Asian J Trop Med Public Health; 1984 Jun; 15(2):194-200. PubMed ID: 6095461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.